The MDCH says a flu vaccine is the single best way to protect against getting the flu.
NanoBio Corp. will get an initial contract of $5.5 million and up to $5 million more to devleop its nanoemulsion technology to improve the performance of flu vaccines.
Ann Arbor-based NanoBio Corp. says newly published experimental data shows that its nanoemulsion-based flu vaccine has elicited robust immunity to the flu in animal tests on ferrets.
Building upon a series of successful preclinical and clinical studies, Ann Arbor-based NanoBio Corp. Tuesday announced the initiation of a second tolerability and immunogenicity study designed to test and further optimize its novel nanoemulsion-based intranasal vaccine adjuvant.
It might seem a little early to start thinking about flu season, but several area hospitals are about to make the “shot in the arm” mandatory for their staff.